Editing Inosine
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
The edit can be undone.
Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 22: | Line 22: | ||
A [https://clinicaltrials.gov/show/NCT02288091 Phase 1 clinical trial] on the effects of inosine on ALS through elevating uric acid is due to be completed in March 2016. | A [https://clinicaltrials.gov/show/NCT02288091 Phase 1 clinical trial] on the effects of inosine on ALS through elevating uric acid is due to be completed in March 2016. | ||
− | + | == Discussion threads on the ALSTDI forum == | |
− | + | ||
+ | [http://www.alstdi.org/forum/yaf_postst47717_regulator-found-for-regenerating-nerve-fibers-in-animals.aspx Regulator found for regenerating nerve fibers in animals]: | ||
+ | :''A possible combined cocktail for nerve regeneration? inosine - target 1. Mst3b 2. GAP-43 3. Talpha-1 tubulin; ibuprofen - target RhoA inhibition; Vitamin D - target CD1c⁺ mDCs/RALDH2 mRNA'' | ||
== ALSUntangled evaluation == | == ALSUntangled evaluation == |